US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

701.33

+15.582.27%

Number of Gainers:84

Number of Losers:64

Number of Flat:6

PE:- -

High:704.53

Open:685.68

Low:683.13

Close:685.75

Volume:80.27M

Turnover:3.06B

Market Cap:489.11B

Float Cap:371.28B

Loading ...

Inovio Q2 Net Loss Narrows on Warrant Gain, Lower Costs

MaxCyte Q2 FY26 Net Loss Narrows 28% to $8.9 Million; Revenue Drops 15% to $7.3 Million

STAAR Surgical Q2 Net Sales Jump on China Sales Growth

Analysts Offer Insights on Consumer Cyclical Companies: Brinker International (EAT) and Global-e Online (GLBE)

Sera Prognostics Q2 FY26 Net Loss Widens to $9.14 Million; Revenue Rises 76.47% to $30,000

RenovoRx Q2 Net Loss Holds at $2.91 Million; Revenue More than Doubled to $909,000 Year over Year

Intapp CEO John T. Hall Disposes of 3,000 Common Shares for $111,120

RenovoRx Q2 Net Income USD -2.911 Million

RenovoRx - Raises Full-Year 2026 Revenue Guidance to $3.75 Mln-$4.25 Mln

THOMSON REUTERS

RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth

THOMSON REUTERS

MaxCyte Q2 Cash & Investments USD 141.9 Million

THOMSON REUTERS

MaxCyte Q2 Gross Profit USD 5.6 Million

THOMSON REUTERS

MaxCyte Q2 EPS USD -0.08

THOMSON REUTERS

MaxCyte: Full Year Revenue Expected to be $30 Million to $32 Million

THOMSON REUTERS

Robinhood Market - Funded Customers at 28.5 Mln at End of July 2026, up 1.77 Mln Year-over-Year

THOMSON REUTERS

Robinhood Markets, Inc. Reports July 2026 Operating Data

THOMSON REUTERS

Robinhood Markets - Total Platform Assets at $355 Bln at End of July 2026, up 19% Year-over-Year

THOMSON REUTERS

Press Release: MaxCyte Reports Second Quarter 2026 Financial Results

Press Release: SERA Prognostics Reports Second Quarter 2026 Financial Results

Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK4539/news?page=44"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":701.3277,"timestamp":1787670294403,"preClose":685.7458,"halted":0,"volume":80269720,"delay":0,"changeRate":0.022723,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":15.581909,"latestTime":"08-25 11:04:54 EDT","open":685.6775,"high":704.52704,"low":683.1322,"amount":3062143736.813012,"amplitude":0.031199,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.436531,"peRate":156.391987,"turnoverRate":0.006227,"increases":84,"decrements":64,"flats":3,"marketCap":489108497115.625,"floatMarketCap":371275975590.3125},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":704.52704,"amplitude":0.031199,"preClose":685.7458,"low":683.1322,"pbRate":"5.436531","latestPrice":701.3277,"volume":80269720,"delay":0,"open":685.6775,"prevYearClose":881.5255,"prevWeekClose":700.9769,"prevMonthClose":673.0273,"prevQuarterClose":742.922,"fiveDayClose":655.4622,"twentyDayClose":704.4272,"sixtyDayClose":779.4826,"secType":"PLATE","market":"US","turnoverRate":0.006227,"peRate":156.391987,"marketCap":489108497115.625,"floatMarketCap":371275975590.3125,"timestamp":1787670294403,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":84,"down":64,"flat":6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:44,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659900699","title":"Inovio Q2 Net Loss Narrows on Warrant Gain, Lower Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900699","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900699?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:14","pubTimestamp":1786565676,"startTime":"0","endTime":"0","summary":"Inovio Q2 net loss narrows on warrant gain, lower costsOverviewUS biotech firm's Q2 net loss narrowed yr/yr, driven by non-cash warrant gainQ2 operating expenses fell due to lower compensation and dev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N449116:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX","BK4539","BK4583","UNCY","BK4568","INO","BK4139","GANX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900637","title":"MaxCyte Q2 FY26 Net Loss Narrows 28% to $8.9 Million; Revenue Drops 15% to $7.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900637","media":"Reuters","labels":["shareholding","corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900637?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:13","pubTimestamp":1786565600,"startTime":"0","endTime":"0","summary":"MaxCyte Q2 FY26 net loss narrows 28% to $8.9 million; revenue drops 15% to $7.3 millionMaxCyte posted Q2 2026 revenue of USD 7.3 million, down 15% from Q2 2025; net loss narrowed to USD 8.9 million.Co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL88FRyg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","MXCT","BCDF","BK4539","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014039.USD","BK4585","LU2210149790.SGD","IE00BN0W2V16.EUR","BK4112","BK4588","IE00B64PRP62.GBP","SG9999014013.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2095319765.USD","NDAQ","SG9999014005.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","BK4121","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659853900","title":"STAAR Surgical Q2 Net Sales Jump on China Sales Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2659853900","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659853900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:11","pubTimestamp":1786565500,"startTime":"0","endTime":"0","summary":"STAAR Surgical Q2 net sales jump on China sales growthOverviewU.S. intraocular lens maker's Q2 net sales rose 111% yr/yr to $93.5 mlnCompany swung to Q2 net income of $8.1 mln, EPS $0.16, from loss a ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N44910N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BK6027","STAA","BK4548","9QX.SI","BK4539","BK4139","BK4588","BK4585","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900418","title":"Analysts Offer Insights on Consumer Cyclical Companies: Brinker International (EAT) and Global-e Online (GLBE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900418","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900418?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:10","pubTimestamp":1786565406,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Consumer Cyclical sector as 2 analysts just weighed in on Brinker International (EAT) and Global-e Onli...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-consumer-cyclical-companies-brinker-international-eat-and-global-e-online-glbe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-consumer-cyclical-companies-brinker-international-eat-and-global-e-online-glbe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4122","LU1559883803.SGD","BK4539","BK4220","EAT","BK4585","BK4588","LU0566484027.USD","GLBE","BK4209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907798","title":"Sera Prognostics Q2 FY26 Net Loss Widens to $9.14 Million; Revenue Rises 76.47% to $30,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907798","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907798?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:08","pubTimestamp":1786565291,"startTime":"0","endTime":"0","summary":"Sera Prognostics Q2 FY26 net loss widens to $9.14 million; revenue rises 76.47% to $30,000Sera Prognostics posted Q2 revenue of USD 30,000, up 76.47% from a year earlier.Net loss widened to USD 9.14 m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL79dh5z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","SERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659758907","title":"RenovoRx Q2 Net Loss Holds at $2.91 Million; Revenue More than Doubled to $909,000 Year over Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2659758907","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659758907?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:07","pubTimestamp":1786565278,"startTime":"0","endTime":"0","summary":"RenovoRx Q2 net loss holds at $2.91 million; revenue more than doubled to $909,000 year over yearRenovoRx posted Q2 revenue of USD 909,000, up 61% sequentially, with gross margin of about 84%.Net loss","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLc6FgZ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU0314104364.USD","SG9999014021.USD","BK4539","NDAQ","LU2095319765.USD","SG9999014039.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU2210149790.SGD","RNXT","BK4588","BK4139","BCDF","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014005.SGD","BK4585","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659077009","title":"Intapp CEO John T. Hall Disposes of 3,000 Common Shares for $111,120","url":"https://stock-news.laohu8.com/highlight/detail?id=2659077009","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659077009?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:07","pubTimestamp":1786565248,"startTime":"0","endTime":"0","summary":"Intapp CEO John T. Hall disposes of 3,000 common shares for $111,120Intapp CEO John T. Hall sold 3,000 common shares on Aug. 10 at USD 37.04.Hall exercised employee stock options for 3,000 shares at U","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLrbv7g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Intapp CEO John T. Hall Disposes of 3,000 Common Shares for $111,120","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","INTA","BK4023","LU0757428866.USD","BK4535","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907214","title":"RenovoRx Q2 Net Income USD -2.911 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907214","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907214?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:06","pubTimestamp":1786565164,"startTime":"0","endTime":"0","summary":"BRIEF-RenovoRx Q2 Net Income USD -2.911 MillionAug 12 (Reuters) - RenovoRx Q2 operating expenses USD 4.115 million.Q2 basic EPS USD -0.06Q2 EPS USD -0.06","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXS0CXZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659163900","title":"RenovoRx - Raises Full-Year 2026 Revenue Guidance to $3.75 Mln-$4.25 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2659163900","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659163900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565105,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXS0CXZZ:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907117","title":"RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907117","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907117?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565104,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA7X9CPG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RNXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907939","title":"MaxCyte Q2 Cash & Investments USD 141.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907939?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565103,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXT0HPLB:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MXCT","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907169","title":"MaxCyte Q2 Gross Profit USD 5.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907169","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907169?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565103,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXT0HPLB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","MXCT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659873900","title":"MaxCyte Q2 EPS USD -0.08","url":"https://stock-news.laohu8.com/highlight/detail?id=2659873900","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659873900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565103,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXT0HPLB:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MXCT","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659551900","title":"MaxCyte: Full Year Revenue Expected to be $30 Million to $32 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659551900","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659551900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565103,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLXT0HPLB:8","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4539","MXCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900963","title":"Robinhood Market - Funded Customers at 28.5 Mln at End of July 2026, up 1.77 Mln Year-over-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900963","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900963?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA6LXBTT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HOOW","BK4539","HOOX","CRPT","BLCK","HOII","HOOY","BPAY","LU1861558580.USD","ROBN","HOOZ","HOOG","FINX","HOYY","LU1861559042.SGD","HOOD","HOOI","BK4547","HODU","BK4127","IAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659071259","title":"Robinhood Markets, Inc. Reports July 2026 Operating Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2659071259","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659071259?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA6LXBTT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HOII","IAI","ROBN","HOYY","HOOW","HOOG","HOOD","HODU","BK4539","LU1861558580.USD","LU1861559042.SGD","HOOX","BLCK","BPAY","BK4127","FINX","CRPT","HOOY","HOOZ","HOOI","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659009469","title":"Robinhood Markets - Total Platform Assets at $355 Bln at End of July 2026, up 19% Year-over-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2659009469","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659009469?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565101,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA6LXBTT:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HOOI","ROBN","HOOX","BK4127","FINX","HOII","HOYY","BLCK","LU1861559042.SGD","HOOY","HOOD","HOOZ","HODU","BPAY","LU1861558580.USD","HOOW","BK4539","HOOG","IAI","BK4547","CRPT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907077","title":"Press Release: MaxCyte Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907077","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907077?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"-- Reports total revenue of $7.3 million for the second quarter of 2026,including $6.5 million of core revenue and $0.8 million of SPL. -- Repurchased approximately $5.5 million of common stock to date under the. Company's $10 million share repurchase program authorized by the Board. -- Following end of quarter, announced strategic, multi-platform technology. of 15% over the second quarter of 2025.-- Core business revenue of $6.5 million in the second quarter of. million for the second quarter of 2026, compared to $0.3 million. -- Gross profit for the second quarter of 2026 was $5.6 million (77% gross. revenue and reserves for excess and obsolete inventory, compared to. non-GAAP adjusted gross margin of 83% in the second quarter of 2025.-- Operating expenses for the second quarter of 2026 were $15.8 million,-- Second quarter 2026 net loss was $8.9 million compared to net loss of","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","MXCT","03160","BK4022","BK4121","TM","BK4604","BK4539","BK4585","BK4555","R","BK4588","BK4099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907036","title":"Press Release: SERA Prognostics Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907036","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907036?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"SALT LAKE CITY, Aug. 12, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company , focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the second quarter ended June 30, 2026.Key Second Quarter and Recent Highlights:-- Advanced Commercial Adoption Strategy with Fourth Partnership Program. Launch: In August 2026, we launched fourth partnership program, expanding. implementation of PreTRM Test-guided care through a state-based. initiative with a national payer. We also exceeded our 2026 payer. engagement objective, with active discussions now spanning more than 20. payer opportunities across over 20 states, and are increasingly focused. on advancing implementation, reimbursement readiness, and adoption within. -- Illinois Medicaid Coverage Mandate Expands Access to PreTRM-Test: In June. requiring Medicaid coverage and reimbursement for prescribed proteomic. blood ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4232","BK4139","SERA","BK4539","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659185537","title":"Allogene Therapeutics Reports Second Quarter 2026 Financial Results and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659185537","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659185537?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"Pivotal Phase 2 ALPHA3 Program in 1L Large B-cell Lymphoma (LBCL): Recent Interim Futility Analysis Supports Cemacabtagene Ansegedleucel’s (Cema-Cel) Potential as an Outpatient, MRD-Guided 1L Consolid","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3344049/0/en/allogene-therapeutics-reports-second-quarter-2026-financial-results-and-business-update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z4B17.USD","BK4022","LU0963586101.USD","BK4007","BK4187","BK4230","BK4006","LENZ","LU2065731478.USD","BK4539","IE0031619046.USD","IE00B66KJ199.SGD","XAR","PYZ","CAR","CRS","BK4139","IE00B7SZL793.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":54,"pageCount":44,"totalSize":1077,"code":"91000000","status":"200"}]}}